Universitatsklinikum Essen

What Universitatsklinikum Essen does

Universitätsklinikum Essen (AöR) is a public-law university hospital in Essen, North Rhine-Westphalia, operating as part of the Universitätsmedizin Essen (UME) group, which comprises 15+ subsidiaries across the Ruhr metropolitan region, including the Ruhrlandklinik, St. Josef Krankenhaus Werden, Herzchirurgie Essen-Huttrop, Westdeutsches Protonentherapiezentrum (WPE) and others. The main hospital runs ~1,700 beds, approximately 33 specialized clinics and 24 research institutes, and is staffed by ~8,000 employees on the main campus (~11,000 across the UME group) with ~700 trainees. It is affiliated with the Medical Faculty of the University of Duisburg-Essen and is classified as a Maximalversorger (maximum-care provider) under the German healthcare system.

Its core clinical portfolio is organized around five supraregional "Westdeutsches" centers: the WTZ oncology center (designated Onkologisches Spitzenzentrum by Deutsche Krebshilfe in partnership with UK Münster), the WZO transplant center (kidney, liver, pancreas, heart, lungs), the WHGZ cardiovascular center, the WZI center for infectious diseases and immunology, and WPE for proton therapy, supplemented by the C-TNBS Center for Translational Neuro- and Behavioral Sciences. Technology assets include a dedicated Institut für KI in der Medizin (IKIM), a hospital-wide Datenintegrationszentrum (DIZ), total-body PET/CT scanners, theranostics (PSMA-PET imaging combined with Lu-177 radioligand therapy), and a Smart Hospital digital transformation program running since 2015. Underlying platforms span AI-enabled PSMA-PET imaging analysis, AI-based survival prediction in prostate cancer (PROMISE-PET registry with >15,000 patients across 50+ institutions), radioligand therapy capacity, proton therapy, and translational research infrastructure.

Commercially, Universitätsklinikum Essen operates within Germany's statutory (GKV) and private (PKV) reimbursement system, generating inpatient revenue through DRG billing, outpatient revenue under EBM, optional Wahlleistungen services, and supplementary teaching funding from the Medical Faculty and external grants (Deutsche Krebshilfe, BMBF, Land NRW, EU, industry-sponsored trials). Patient acquisition is non-commercial and driven by medical reputation, physician referrals, emergency and inter-hospital transfers, and self-referral to specialized outpatient clinics, with demand-generation relying on academic publications, conferences, and partnerships rather than traditional marketing.

Name

Universitatsklinikum Essen

Legal name

Universitätsklinikum Essen (AöR)

Website

https://uk-essen.de

Company type

Private

Founded year

1909

Operating status

Operating

Short description

Universitätsklinikum Essen is a German maximum-care university hospital serving statutory and private patients across 33 clinics and 24 institutes, anchored by supraregional Westdeutsches centers in oncology, transplantation, cardiovascular medicine, infectiology, and proton therapy.

Ownership category

akta.pro rank

Product category

Academic / University Hospital Services (Tertiary Healthcare)

NAICS

General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (6215)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Transplant Specialty Hospitals (HLAFAHAE), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• University hospital services
• Oncology treatment
• Organ transplantation
• Proton therapy
• Medical research

Headquarters

HQ city

Essen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Healthcare Services (Statutory & Private Health Insurance): As a German university hospital, the primary revenue stream is reimbursement for medical services rendered to inpatients and outpatients covered under the German statutory health insurance system (GKV) and private health insurance (PKV). Revenue is generated through Diagnosis-Related Groups (DRG) billing for inpatient care, outpatient treatment codes (EBM), and individual healthcare services. As a maximum care provider (Maximalversorger), it covers the full spectrum of medical specialties.
2. Research Grants & Third-Party Funding: Significant funding from Deutsche Krebshilfe (German Cancer Aid) for oncology networks, federal and state government research grants (BMBF, Land NRW), EU research programmes, and industry-sponsored clinical trials. WTZ Essen is funded as an Onkologisches Spitzenzentrum (Oncological Center of Excellence) by Deutsche Krebshilfe in partnership with UK Münster.
3. Teaching & Education: Medical education revenue through the Medical Faculty of the University of Duisburg-Essen, including tuition-related funding from the state of North Rhine-Westphalia, continuing medical education programmes, and simulation/training centre operations.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

Core offering

Universitätsklinikum Essen is a tertiary university hospital providing maximum-care medical services across 33 specialty clinics and 24 research institutes, with flagship offerings in oncology (radioligand/theranostics, proton therapy, stem cell transplantation), organ transplantation of all vital organs, cardiovascular medicine, infectious diseases, neurology, and AI-enabled diagnostics. It also conducts translational research and undergraduate/graduate medical education through its affiliation with the Medical Faculty of the University of Duisburg-Essen.

Product overview

Universitätsklinikum Essen is a leading healthcare and competence center in the Ruhr metropolitan region, operating as part of the Universitätsmedizin Essen hospital group with 33 clinics, 24 institutes, and approximately 11,000 employees. The hospital functions as an integrated academic medical center with specialized focus areas including Oncology (WTZ), Cardiovascular Medicine (WHGZ), Infectious Diseases (WZI), Transplantation (WZO), Proton Therapy (WPE), and Translational Neuroscience (C-TNBS). The hospital is on a Smart Hospital transformation journey since 2015, incorporating AI-enabled imaging technologies and participating in international research collaborations such as the PROMISE-PET AI registry with Telix Pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• Westdeutsches Tumorzentrum Essen (WTZ): Comprehensive cancer center of the university hospital, recognized as an Oncology Center of Excellence by the German Cancer Aid (Deutsche Krebshilfe), operating in network with University Hospital Münster
• Westdeutsches Protonentherapiezentrum (WPE)
• Westdeutsches Herz- und Gefäßzentrum (WHGZ)
• Westdeutsches Zentrum für Organtransplantation (WZO)
• Westdeutsches Zentrum für Infektiologie (WZI)
• Center for Translational Neuro- and Behavioral Sciences (C-TNBS)
• Westdeutsches Kopfschmerzzentrum
• Westdeutsches Magen- und Darmzentrum
• UME+ Vorteile
• Smart Hospital
• Green Hospital
• Zentrum für Intensivmedizin Metropole Ruhr (ZIMR)
• Zentrum für interdisziplinäre Telemedizin und Telecare (ZinTT)
• Zentrum für virtuelle und erweiterte Realität in der Medizin (ZvRM)

Products and services

• Westdeutsches Tumorzentrum Essen (WTZ) Comprehensive cancer center at Universitätsklinikum Essen delivering multimodal oncology services — medical oncology, radiation therapy, proton therapy, surgical oncology, hematology, stem cell transplantation, theranostics (Lu-177) and PSMA-PET imaging — to cancer patients referred regionally, nationally, and via the WTZ-Netzwerk partnership.
• Westdeutsches Herz- und Gefäßzentrum Essen (WHGZ) Cardiovascular maximum-care center integrating cardiology, angiology, neurology, cardiac and thoracic surgery, vascular surgery, and pediatric cardiology with scientific institutes — for patients with complex cardiovascular conditions in the Ruhr region and beyond.
• Westdeutsches Zentrum für Organtransplantation (WZO) Transplantation program offering all vital organ transplants (kidney, liver, pancreas, heart, lungs) with living-donor programs and pre/post-transplant care, serving patients awaiting transplantation nationally and internationally referred.
• Westdeutsches Protonentherapiezentrum Essen (WPE) Proton beam therapy service (particle therapy) for cancer patients, providing precision irradiation to pediatric and adult oncology cases referred across the Ruhr region and beyond.
• Westdeutsches Zentrum für Infektiologie (WZI) Center for infectious disease medicine focused on HIV/AIDS, virology, immunology, immune-mediated disorders, and rare or complex infections, serving patients via outpatient specialty clinics and inpatient care at Universitätsklinikum Essen.
• Center for Translational Neuro- and Behavioral Sciences (C-TNBS) Translational neuroscience and behavioral research center combining neurological, psychiatric, and behavioral science groups across 19 clinics/institutes, pairing research programs (stroke, neuro-oncology, multiple sclerosis, pain, neuroimmunology, neuropsychiatry) with clinical services for affected patients.
• PROMISE-PET Registry (PSMA-PET AI research platform) International multi-center registry and AI platform that standardizes PSMA-PET imaging readings from more than 15,000 prostate cancer patients to develop and validate AI-based survival prediction models, used clinically and for research collaboration partners.
• Emergency Medicine (Zentrum für Notfallmedizin) 24/7 emergency department providing initial and specialized emergency medical care across all specialties, including inter-hospital referrals and large-area emergency medical services for the Ruhr region.
• Westdeutsches Tumorzentrum Netzwerk (WTZ-Netzwerk) Multi-center oncology research and care network jointly operated by Universitätsklinikum Essen and Universitätsklinikum Münster as a Deutsche Krebshilfe Spitzenzentrum, providing optimal cancer care and clinical-trial access across both university hospitals.

Quantifiable outcome

• PET scans more than doubled from 2015 to 2024 at Essen, demonstrating rapid scaling of imaging capacity
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Telix PharmaceuticalscoreStrategic or Co-development Partner · 27 February 2026Research collaboration joining the PROMISE-PET registry — a multi-center prospective observational study assessing prognostic value of PSMA-PET imaging in prostate cancer using AI. Telix contributes its automated machine learning platform and gallium-68 (68Ga)-PSMA-11-PET imaging data. The partnership aims to develop and validate AI-based survival prediction models. Registry includes >15,000 patients from 50+ global institutions.
• ICPO Foundation (International Centers for Precision Oncology)coreStrategic or Co-development Partner · 19 October 2025Global partnership to establish standardized theranostics centers. ICPO Foundation works to create a global network of precision oncology centers using standardized theranostic approaches. Essen contributes expertise in radioligand therapeutics and PSMA-targeted therapies.
• Munich Precision Oncology InitiativecoreStrategic or Co-development Partner · 19 October 2025Collaboration between Munich-based precision oncology centres and UK Essen to establish standardized theranostics care pathways, share best practices for radioligand therapy scaling, and develop KPIs for referral timeline optimization across Germany.
• University Hospital Münster (UK Münster)coreStrategic or Co-development PartnerWTZ Essen cancer center operates jointly with the cancer center of UK Münster as an Oncological Center of Excellence (Spitzenzentrum), funded by Deutsche Krebshilfe. The two centers collaborate on research, clinical trials, and best practice sharing within Germany's premier cancer care network.
• PROMISE-PET Registry Partners (50+ Global Institutions)coreStrategic or Co-development PartnerInternational multi-center prospective observational registry standardizing PSMA-PET readings across >50 institutions globally since 2018. UK Essen joined the registry in 2026, contributing and accessing standardized imaging data from >15,000 prostate cancer patients to support AI model development.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Charité – Universitätsmedizin Berlin: Germany's largest university hospital and a joint institution of Freie Universität Berlin and Humboldt-Universität. Comparable to Essen as a public AMC offering the full spectrum of specialties, with strong oncology, transplant, and research programs and a similar state-governance model.
• Universitätsklinikum Heidelberg: One of Germany's leading university hospitals and a major oncology center (National Center for Tumor Diseases). Comparable to Essen through its Spitzenzentrum cancer designation, proton/heavy-ion therapy (HIT), and extensive clinical research portfolio.
• LMU Klinikum – Ludwig-Maximilians-Universität München: Large Munich-based university hospital covering the full spectrum of medical specialties with strong oncology, transplant, and cardiovascular programs. Comparable to Essen in scale, public governance structure, and role as a maximum-care provider in its region.
• Universitätsklinikum Münster (UKM): University hospital in North Rhine-Westphalia and direct partner of Essen's WTZ Spitzenzentrum cancer network. Operates as a maximum-care provider in NRW with overlapping oncology, transplant, and cardiovascular specialties, making it both a peer and a collaborator.
• Universitätsklinikum Köln: University hospital of the University of Cologne providing comprehensive specialty care, oncology, and transplantation in NRW. Comparable as a regional maximum-care AMC competing for similar patient referrals and research talent within North Rhine-Westphalia.
• Universitätsklinikum Frankfurt: Goethe University Frankfurt's university hospital with a comprehensive specialty portfolio including strong oncology and hematology. Comparable to Essen as a public AMC of similar size, attracting complex cases from its metropolitan catchment area.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Hamburg's university hospital and one of northern Germany's largest AMCs. Comparable to Essen as a publicly governed maximum-care provider with strong research output across oncology, neuroscience, and translational medicine.
• Universitätsklinikum Tübingen: University hospital with notable strengths in oncology, neurology, and rare diseases. Comparable to Essen as a German AMC with a research-intensive profile and similar public-institution governance structure.
• Universitätsklinikum Würzburg: Bavarian university hospital with comprehensive specialty coverage including a strong transplant program and CCC oncological center. Comparable to Essen as a regional maximum-care AMC competing for complex-case referrals and research funding.

Broad incumbents

• Helios Kliniken: Europe's largest private hospital operator with broad inpatient and outpatient coverage in Germany. Comparable to Essen in service breadth and scale, but operates a private commercial model versus Essen's public AMC mission, making it an adjacent benchmark for inpatient capacity and digital hospital initiatives.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCtrJZc2C2gYxOwBaG1EzAeg
• Facebookfacebook.com/ukessen
• LinkedInde.linkedin.com/company/universit%C3%A4tsmedizinessen
• Instagraminstagram.com/universitaetsmedizinessen
• Xx.com/ukessenpr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Universitatsklinikum Essen